B. Austen

发表

Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas

F Menestrina, T. Stankovic, R. Küppers, 2005, Leukemia.

Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients

T. Stankovic, P. Byrd, A. Taylor, 2008, British journal of haematology.

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.

T. Stankovic, C. Fegan, R. Hills, 2008, Blood.

A study of the role of ATM mutations in the pathogenesis of B-cell chronic lymphocytic leukaemia

B. Austen, 2007 .

South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients

C. Fegan, P. Moss, B. Austen, 2008, British journal of haematology.

Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL.

T. Stankovic, C. Fegan, P. Moss, 2005, Blood.

Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling.

T. Stankovic, P. Moss, A. Taylor, 2004, Blood.

Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.

R. Siebert, M. Dyer, T. Stankovic, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele

M. Dyer, T. Stankovic, C. Fegan, 2012, Haematologica.

A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL

M. Dyer, T. Stankovic, B. Austen, 2008, Leukemia.

Fatal disseminated fusarium infection in acute lymphoblastic leukaemia in complete remission

B. Austen, A. Duncombe, B. Wilkins, 2001, Journal of clinical pathology.

Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia

Thomas L. Dunwell, T. Stankovic, B. Austen, 2009, Epigenetics.

A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival.

David P Lane, T. Stankovic, C. Fegan, 2005, Blood.

Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses.

T. Stankovic, G. Stewart, P. Byrd, 2004, Blood.

Calreticulin mutations and their importance in splanchnic vein thrombosis

B. Austen, D. Patch, M. Sekhar, 2016, British journal of haematology.

A case of lymphoma presenting as splenic infarction

B. Austen, C. Tomson, P. Boddana, 2009, BMJ Case Reports.

Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy

B. Austen, S. Hewamana, J. Murray, 2009, European journal of haematology.

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.

T. Stankovic, C. Fegan, R. Hills, 2008, Blood.